Flupentixol-t-melitracen tablets, a new antidepressant drug of hisilic, will be used for the first time in the field

According to the website of the State Food and Drug Administration (CFDA) on April 15, six kinds of new antidepressant drug of Hisilicon, Flupentixol and melitracen tablets, entered the site for inspection, which means that the drug only needs to pass the inspection link of production environment and production process to impact the first reference date in China Flupentixicine tablet is an anti anxiety psychoactive drug It mainly treats neurasthenia, psychogenic depression, depressive neurosis, hidden depression, psychosomatic diseases with anxiety and apathy, menopausal depression, alcoholism and drug addicts' restlessness and depression The product name of flupentixomil tablets is "delixin" The original research manufacturer is Denmark Lingbei Pharmaceutical Co., Ltd at present, only the original research drugs are sold in China Domestic companies including Enhua Pharmaceutical Co., Ltd and Hainan Yier Pharmaceutical Co., Ltd are in the state of "in review" Hisic has been ahead of other enterprises and is the first to prepare for on-site inspection Hisico is the leader in the field of parenteral nutrition medicine, characteristic anti infection medicine and hepatobiliary disease medicine In the prospectus, the company has said that it will focus on tracking the development trend of innovative generic drugs in the international mainstream market, and establish the domestic leading new drug variety reserve resources The Research Report of Guolian securities also points out that as one of the heavyweight new drugs with huge potential, droperidol tablets are expected to be approved for production in 2014.